ID: ALA4294966

Max Phase: Preclinical

Molecular Formula: C15H26N2O3

Molecular Weight: 282.38

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC12CC3CC(N)(C1)CC(CCCO[N+](=O)[O-])(C3)C2

Standard InChI:  InChI=1S/C15H26N2O3/c1-2-13-6-12-7-14(9-13,4-3-5-20-17(18)19)11-15(16,8-12)10-13/h12H,2-11,16H2,1H3

Standard InChI Key:  RUNCRKLIIJZQOQ-UHFFFAOYSA-N

Associated Targets(non-human)

Aorta 2975 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 282.38Molecular Weight (Monoisotopic): 282.1943AlogP: 3.05#Rotatable Bonds: 6
Polar Surface Area: 78.39Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 10.70CX LogP: 2.66CX LogD: -0.18
Aromatic Rings: 0Heavy Atoms: 20QED Weighted: 0.46Np Likeness Score: 0.20

References

1. Liu Z, Yang S, Jin X, Zhang G, Guo B, Chen H, Yu P, Sun Y, Zhang Z, Wang Y..  (2017)  Synthesis and biological evaluation of memantine nitrates as a potential treatment for neurodegenerative diseases.,  (1): [PMID:30108699] [10.1039/C6MD00509H]

Source